Erythromycin DR 250mg Capsules
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food, unless your doctor advises you to take it differently. Swallow the medication whole - do not chew, break, or crush it. Continue taking your medication as directed by your doctor or healthcare provider, even if you start feeling well.
Storing and Disposing of Your Medication
Store your medication at room temperature in a dry place, avoiding the bathroom. Keep all medications in a safe location, out of the reach of children and pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you have questions about disposing of your medication, consult your pharmacist. You may also want to check if there are drug take-back programs available in your area.
What to Do If You Miss a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take the medication exactly as prescribed by your doctor, even if you start to feel better. Do not skip doses or stop taking it early, as this can lead to antibiotic resistance.
- Swallow the delayed-release capsules whole; do not crush, chew, or break them.
- Take with a full glass of water.
- Avoid taking with grapefruit juice, as it can increase the levels of erythromycin in your body.
- Inform your doctor about all other medications you are taking, including over-the-counter drugs, herbal supplements, and vitamins, as erythromycin can interact with many drugs.
Available Forms & Alternatives
Available Strengths:
- Erythromycin Ophth Oint 3.5gm
- Erythromycin 2% Gel 60gm
- Erythromycin 2% Gel 30gm
- Erythromycin Ophth Oint 1gm Sgl/use
- Erythromycin 2% Topical Soln 60ml
- Erythromycin DR 250mg Capsules
- Erythromycin Ophth Oint 1gm Sgl/use
- Erythromycin Base 250mg Tablets
- Erythromycin Base 500mg Tablets
- Erythromycin Ethyl 400mg/5ml Susp
- Erythromycin Eth 400mg Tablets
- Erythromycin 250mg DR Tablets
- Erythromycin 333mg EC Tablets
- Erythromycin 500mg EC Tablets
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of a severe skin reaction (Stevens-Johnson syndrome/toxic epidermal necrolysis), such as:
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Red or irritated eyes
+ Sores in the mouth, throat, nose, or eyes
Difficulty urinating or changes in urine output
Severe dizziness or fainting
Rapid heartbeat
Abnormal heartbeat (long QT on ECG), which can be life-threatening. This risk may increase when taking other medications with this drug. Seek medical help immediately if you experience an irregular heartbeat.
Diarrhea, particularly a severe form called C. diff-associated diarrhea (CDAD), which can lead to life-threatening bowel problems. Contact your doctor right away if you experience:
+ Stomach pain
+ Cramps
+ Watery, bloody, or loose stools
Hearing loss, which is rare but may be more likely if you have kidney problems or take high doses of this medication. If you experience hearing problems, such as hearing loss, contact your doctor immediately.
Other Possible Side Effects
Most people do not experience severe side effects, but some may occur. If you notice any of the following symptoms or if they persist or bother you, contact your doctor:
Diarrhea
Stomach pain
Upset stomach
Vomiting
Decreased appetite
This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe, watery diarrhea or bloody stools (may occur up to 2 months after stopping treatment)
- Yellowing of the skin or eyes (jaundice)
- Unusual tiredness or weakness
- Dark urine
- Severe stomach pain
- Chest pain, fluttering in your chest, shortness of breath, or sudden dizziness (signs of heart rhythm problems)
- Hearing loss or ringing in the ears (tinnitus)
- Signs of a severe allergic reaction (rash, itching, swelling of face/tongue/throat, severe dizziness, trouble breathing)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, such as:
+ Abnormal heartbeat patterns, including a prolonged QTc interval on an electrocardiogram (ECG)
+ Slow heartbeat
+ Low potassium or magnesium levels
Additionally, tell your doctor about all the medications you are currently taking, including:
Prescription and over-the-counter (OTC) medications
Natural products
* Vitamins
This is crucial because some medications, such as those used to treat mood disorders, abnormal heart rhythms, or migraine headaches, may interact with this medication and should not be taken together.
It is not possible to list all the medications and health conditions that may interact with this drug. Therefore, it is vital to discuss all your medications and health problems with your doctor and pharmacist to ensure safe use.
Do not start, stop, or change the dose of any medication without first consulting your doctor to confirm it is safe to do so with this medication.
Precautions & Cautions
It is crucial that you inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
If you are taking this medication long-term, your doctor may recommend regular blood tests to monitor your condition. Be sure to discuss this with your doctor.
Please note that this medication may interfere with certain laboratory tests. It is essential to notify all of your healthcare providers and laboratory personnel that you are taking this medication.
Do not take this medication for longer than prescribed by your doctor, as this may increase the risk of a second infection.
If you are following a low-sodium or sodium-free diet, consult with your doctor before taking this medication, as some products may contain sodium.
If you have myasthenia gravis, it is essential to discuss your condition with your doctor. Monitor your symptoms closely, and contact your doctor immediately if they worsen. Additionally, be aware that myasthenia gravis symptoms, such as new or worsening muscle weakness, difficulty chewing or swallowing, breathing problems, droopy eyelids, or changes in vision (including blurred vision or double vision), can occur in people without a prior diagnosis of the condition. If you experience any of these symptoms, seek medical attention promptly.
Special Considerations
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
If you are pregnant, planning to become pregnant, or breastfeeding, consult with your doctor to discuss the potential benefits and risks to you and your baby.
Newborns
In rare cases, newborns taking this medication may develop a severe stomach condition. If your child vomits or becomes irritable during feeding, contact your doctor immediately.
Overdose Information
Overdose Symptoms:
- Severe nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Hearing loss (reversible)
- Liver dysfunction
- Cardiac arrhythmias (rare)
What to Do:
In case of overdose, seek immediate medical attention or call a poison control center (e.g., 1-800-222-1222). Treatment is supportive and symptomatic. Gastric lavage may be considered if ingestion is recent. Monitor cardiac function (ECG) and liver function.
Drug Interactions
Contraindicated Interactions
- Pimozide
- Ergot alkaloids (e.g., ergotamine, dihydroergotamine)
- Colchicine (in patients with renal or hepatic impairment)
Major Interactions
- Statins (e.g., simvastatin, lovastatin, atorvastatin) - increased risk of rhabdomyolysis
- Antiarrhythmics (e.g., amiodarone, disopyramide, dofetilide, dronedarone, procainamide, quinidine, sotalol) - increased risk of QT prolongation and Torsades de Pointes
- Calcium channel blockers (e.g., verapamil, diltiazem, amlodipine, felodipine) - increased levels of CCBs, leading to hypotension, bradycardia
- Warfarin - increased anticoagulant effect
- Carbamazepine - increased carbamazepine levels, leading to toxicity
- Theophylline - increased theophylline levels, leading to toxicity
- Sildenafil, Tadalafil, Vardenafil - increased PDE5 inhibitor levels
- Tacrolimus, Cyclosporine - increased immunosuppressant levels, leading to nephrotoxicity
- Cisapride (removed from market in many countries due to QT prolongation)
- Other drugs known to prolong QT interval (e.g., some antipsychotics, antidepressants, fluoroquinolones)
Moderate Interactions
- Benzodiazepines (e.g., midazolam, triazolam) - increased sedation
- Corticosteroids (e.g., methylprednisolone) - increased corticosteroid levels
- Digoxin - increased digoxin levels
- Phenytoin - altered phenytoin levels
- Oral contraceptives - theoretical risk of reduced efficacy (though not consistently proven)
- Zidovudine - decreased zidovudine levels
- Clindamycin, Lincomycin, Chloramphenicol - antagonism of antibacterial effects
Minor Interactions
- Antacids (aluminum/magnesium hydroxide) - may reduce absorption of some erythromycin formulations (less relevant for DR)
Monitoring
Baseline Monitoring
Rationale: To establish baseline for patients with pre-existing hepatic impairment or those on prolonged therapy, due to risk of hepatotoxicity.
Timing: Prior to initiation of therapy for at-risk patients.
Rationale: While not typically requiring dose adjustment, severe renal impairment may warrant caution and closer monitoring.
Timing: Prior to initiation for patients with known or suspected renal impairment.
Routine Monitoring
Frequency: Daily
Target: Resolution of infection symptoms
Action Threshold: Lack of improvement or worsening symptoms may indicate treatment failure or resistance.
Frequency: Daily, especially during prolonged therapy
Target: Absence of symptoms
Action Threshold: Presence of symptoms warrants immediate discontinuation and LFTs.
Frequency: Daily
Target: Tolerable or absent
Action Threshold: Severe or persistent GI upset may require dose reduction or discontinuation.
Frequency: As clinically indicated, especially in patients with risk factors for QT prolongation or on concomitant QT-prolonging drugs.
Target: Normal QT interval (corrected QT <450 ms for men, <470 ms for women)
Action Threshold: Significant QT prolongation (>500 ms or increase >60 ms from baseline) warrants discontinuation and cardiac evaluation.
Symptom Monitoring
- Severe or persistent diarrhea (may indicate C. difficile-associated diarrhea)
- Yellowing of skin or eyes (jaundice)
- Dark urine
- Unusual fatigue or weakness
- Abdominal pain (especially right upper quadrant)
- Chest pain, palpitations, irregular heartbeat, dizziness, fainting (signs of QT prolongation)
- Hearing loss or tinnitus (rare, usually reversible ototoxicity)
Special Patient Groups
Pregnancy
Erythromycin is generally considered safe for use during pregnancy (Category B). Studies in pregnant women have not shown an increased risk of fetal abnormalities. It is often used as an alternative for penicillin-allergic pregnant women.
Trimester-Specific Risks:
Lactation
Erythromycin is excreted into breast milk in small amounts. It is generally considered compatible with breastfeeding (Lactation Risk Category L2 - Likely Compatible). Monitor breastfed infants for potential adverse effects such as diarrhea, candidiasis (thrush, diaper rash), or allergic reactions.
Pediatric Use
Erythromycin is widely used in pediatric patients. Dosing is weight-based. Caution is advised in neonates due to potential for infantile hypertrophic pyloric stenosis (IHPS), especially with erythromycin ethylsuccinate. Delayed-release formulations are generally not recommended for very young infants due to swallowing difficulties.
Geriatric Use
No specific dose adjustment is required based solely on age. However, elderly patients may be more susceptible to QT prolongation and hearing loss, especially if they have pre-existing cardiac conditions, electrolyte imbalances, or renal/hepatic impairment. Monitor closely for adverse effects and drug interactions.
Clinical Information
Clinical Pearls
- Erythromycin is a potent CYP3A4 inhibitor, leading to numerous significant drug interactions. Always review concomitant medications carefully.
- While generally well-tolerated, GI upset (nausea, vomiting, abdominal cramps) is a common side effect, especially with higher doses or non-enteric coated forms. Delayed-release formulations aim to reduce this.
- Erythromycin can prolong the QT interval and should be used with caution in patients with known QT prolongation, uncorrected hypokalemia/hypomagnesemia, bradycardia, or those receiving other QT-prolonging drugs.
- It is an effective alternative for patients with penicillin allergies, particularly for respiratory tract infections, skin infections, and atypical pneumonia.
- Infantile hypertrophic pyloric stenosis (IHPS) has been reported in neonates receiving erythromycin, particularly erythromycin ethylsuccinate. Use with caution in this population.
Alternative Therapies
- Other macrolides (e.g., azithromycin, clarithromycin)
- Penicillins (e.g., amoxicillin, penicillin V)
- Cephalosporins (e.g., cephalexin, cefdinir)
- Tetracyclines (e.g., doxycycline)
- Fluoroquinolones (e.g., levofloxacin, moxifloxacin)
- Clindamycin